O Polimorfismo no códon 98 do gene de galectina-3 não está associado a tumores benignos e malignos de tiróide

Galectin-3 is a multifunctional protein highly expressed in thyroid cancer. The galectin-3 gene (LGALS3) has several annotated candidates SNPs, however the relationship between galectin-3 SNPs and specific phenotypic variations relevant to health has not been evaluated. In this study, we investigated SNPs in the galectin-3 gene and a putative association with thyroid tumorigenesis. The presence of LGALS3 SNPs in thyroid carcinoma cell lines (NPA, TPC-1, WRO, ARO), thyroid tissues of 55 patients with multinodular goiter or papillary carcinoma diagnosis and lymphocytes of peripherical blood of 45 healthy individuals was evaluated by sequencing and SSCP. The analysis of LGALS3 coding sequence showed that the T98P site presents a great genotypic variation, since we observed both homozygous (AA or CC) and heterozygous (AC) patterns. In thyroid carcinoma cell lines, the genotype of NPA in the LGALS3 T98P site is CC, while TPC-1, WRO and ARO are AC. The genotypic frequency of T98P SNP observed in multinodular goiter (AC= 67%; AA= 23%; CC= 10%) and papillary carcinoma (AC= 68%; AA= 20%; CC= 12%) were similar to the frequency observed in the control population (AC= 60%, AA= 24%, CC= 16%). In conclusion, no association between LGALS3 T98P genotype and the phenotype of the benign or malignant thyroid tumor was observed.

[1]  A. Vecchione,et al.  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions , 2001, The Lancet.

[2]  M. Papotti,et al.  Galectin-3: Presurgical marker of thyroid follicular epithelial cell-derived carcinomas , 2004, Journal of endocrinological investigation.

[3]  S. Chanock,et al.  SNPs in cancer research and treatment , 2004, British Journal of Cancer.

[4]  T. Yoshii,et al.  Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. , 2001, International journal of oncology.

[5]  S. Jeremiah,et al.  Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma. , 2005, Thyroid : official journal of the American Thyroid Association.

[6]  A. Rademaker,et al.  TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[8]  Y. Honjo,et al.  The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. , 1999, Cancer research.

[9]  L. Ward,et al.  Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. , 2004, Cancer letters.

[10]  R. Lotan,et al.  Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. , 1995, The American journal of pathology.

[11]  W. Foulkes,et al.  Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. , 2003, Carcinogenesis.

[12]  T. Yoshii,et al.  Expression of galectin‐3 in fine‐needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms , 1999, Cancer.

[13]  E. Kimura,et al.  Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  G. Fontanini,et al.  Thyroid papillary carcinoma: preliminary evidence for a germ-line single nucleotide polymorphism in the Fas gene. , 2004, The Journal of endocrinology.

[15]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[16]  A. Longatto-Filho,et al.  Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas , 2001, Endocrine pathology.

[17]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[18]  Douglas N W Cooper,et al.  Galectinomics: finding themes in complexity. , 2002, Biochimica et biophysica acta.

[19]  G. Heinze,et al.  Polymorphisms in exon 13 and intron 14 of the RET protooncogene: genetic modifiers of medullary thyroid carcinoma? , 2005, The Journal of clinical endocrinology and metabolism.